BNET Industries

Market Cap:$168.5K
Last Fiscal Year Sales:$1.0M
  • Public
  • CA
Dow Jones Description

We market and distribute bioscience products designed to enhance the well-being and health of individuals. Bioscience products are natural compounds that have health promoting, disease preventing or medicinal properties. We believe that consumers are deeply concerned about the management and cost of their health care and the expensive, chemical-based prescription drug approach predominant in modern medicine. We believe that this concern will increase the demand for bioscience health products because natural products are considered to be effective against many ailments and are more accessible than prescription medications. The global market for herbal products is currently estimated to be $62 billion and the World Health Organization has estimated that the global market for herbal products will be worth $5 trillion dollars by the year 2050. Swiss Medica, Inc., a Delaware corporation, was, prior to May 16, 2003, a holding company focused on acquiring, expanding and developing technology companies and we had no operations.

Contact Information

53 Yonge Street, 3rd Floor

Ontario M5E 1J3

swissmedica.com

416-657-4134

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

Decision Makers

Name (plus bio) Position
Raghu Kilambi CEO
Grant Johnson President, Chief Operating Officer and Director
Bruce Fairbairn Chief Financial Officer
Raghunath Kilambi Financial Officer and Director
Bryson Farrill Advisor

Board of Directors

Name (plus bio) Position
Charlie Orr Board of Directors
Ronald Springer Board of Directors
Sam Halim Board of Directors

Organization Position Status
Swiss Medica, Inc. CEO Current

Organization Position Status
Swiss Medica, Inc. President, Chief Operating Officer and Director Current

Organization Position Status
Swiss Medica, Inc. Chief Financial Officer Current

Organization Position Status
Swiss Medica, Inc. Financial Officer and Director Current

Organization Position Status
Stargold Mines, Inc. CEO and Director Current
Swiss Medica, Inc. Advisor Current
Swiss Medica, Inc. Chairman Current
Stargold Mines, Inc. Board of Directors Current

Organization Position Status
Wine Tasting Party Board Member Current
The Wine Club Inc. Board Member Current
Wineshop At Home Board Member Current
Swiss Medica, Inc. Board of Directors Current
Wine Tasting Board Member Current
Wine Gifts and Wine Jobs Board Member Current
Shaklee Corporation CEO Former
Shaklee Corporation President Former
Direct Selling Association Chairman Former
Provident Mutual Life Insurance Company Director Former
Herbalife Ltd. Board of Directors Former
University of Connecticut MBA Former
Wesleyan University BA Former

Ronald Springer has served as a Director since May 2003. Mr. Springer has been the President and CEO of General Cosmetics Corporation since 1993. Prior to building General Cosmetics, he founded several other companies, including Heaven from Earth Corp., Ceo-Capital Corp, Global Capital Security Inc., Limardo Productions, ISB Overseas GmbH and Doitsu Shinpo. He also held positions at Esarco LTD. and Hynolds Ltd. No individual on our Board of Directors possesses all of the attributes of an audit committee financial expert and no one on our Board of Directors is deemed to be an audit committee financial expert. In forming our Board of Directors, we sought out individuals who would be able to guide our operations based on their business experience, both past and present, or their education. Our business model is not complex and our accounting issues are straightforward. Responsibility for our operations is centralized within management, which is comprised of four people. We rely on the assistance of others, such as our accountant, to help us with the preparation of our financial information. We recognize that having a person who possesses all of the attributes of an audit committee financial expert would be a valuable addition to our Board of Directors, however, we are not, at this time, able to compensate such a person therefore, we may find it difficult to attract such a candidate.

Organization Position Status
Swiss Medica, Inc. Board of Directors Current

Sam Halim has served as a Director since February 20, 2006. Mr. Halim is a trained physician and has over 15 years of business experience in the healthcare, financial services and real estate industries. Mr. Halim founded, acquired and managed Pinnacle Healthcare Technologies a company that operated multiple medical service facilities in Florida, which he sold in February 2002. Mr. Halim has served as an advisory member of GPE, Inc., a company that offers marketing and consulting services to technology and financial institutional service providers. Mr. Halim recently launched North American Physicians Inc. to distribute Swiss Medica's OTC products to the healthcare industry. Mr. Halim studied at University of Cairo Medical School (in association with University of London), New Jersey School of Osteopathic Medicine and Columbia University.

Organization Position Status
Swiss Medica, Inc. Board of Directors Current
advertisement
SWME $0.00090 -0.00000 (-0% )
Volume 18,500
Shares Outstanding 168.5M
Market Cap 168.5K
Year High 0.019
Year Low 0.00010
Earnings Per Share 0.00
P/E Ratio N/A
Dividend 0.00
Yield 0.00
advertisement
Click Here